The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Is Helping Rheumatology Practices Meet COVID-19 Challenges

The ACR Is Helping Rheumatology Practices Meet COVID-19 Challenges

July 15, 2020 • By Ellen M. Gravallese, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Reopening Practices During the Pandemic

Many practices have continued seeing urgent patients via in-person visits during the pandemic, including patients with acute disease flares and those with active, high-risk disease. The ACR has provided guidance for deciding which patients need to be seen in person and which can be accommodated via telemedicine. We have also issued guidance for best practices for necessary in-office infusions, including disinfection, hygiene and screening procedures. We have argued against indiscriminate expansion of home infusions, which pose safety concerns for some patients.

You Might Also Like
  • COVID-19: Practical Tips for Practices
  • COVID-19 Poses Training Challenges for Rheumatology Fellows
  • The ACR on Air Podcast’s COVID-19 Series
Explore This Issue
July 2020
Also By This Author
  • ACR Convergence 2020: Reimagining the ACR/ARP Annual Meeting

As stay-at-home orders have lifted, many rheumatology practices are beginning to reopen and are scheduling a higher percentage of patients for in-
person and non-urgent visits. Although we lack hard and fast rules for best practices, an advisory document on reopening is now available on the ACR website. In
making such decisions, practitioners should consider regional prevalence and new infection rates of SARS-CoV-2 on an ongoing basis. Clinics should also plan for the possibility that scaling back may again be necessary if there is a resurgence of disease locally.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Following guidance from the Centers for Disease Control & Prevention, prac­titioners may contemplate reopening in stages, screening employees for symptoms, requiring mask use by patients and staff, and employing strict infection-control measures. Many physical arrangements can facilitate appropriate distancing, such as using Plexiglas barriers and having patients wait in their cars for appointments, if feasible. Clinicians may also want to consider pro­actively developing a plan to be used if an asymptomatic patient tests positive after a clinic visit.

We also recommend clinicians consult the clinical guidance documents provided by the ACR. In addition to a document addressing the care of adult rheumatology patients, two new documents have been prepared by the ACR’s COVID-19 Pediatric Rheumatology Clinical Guidance Task Force. The first addresses the care of pediatric rheumatology patients in during the COVID-19 pandemic. The second document takes on the identification and management of the newly described multi-system inflam­matory syndrome (MIS-C) seen in children with COVID-19.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Continued Advocacy & HCQ Recommendations

At the ACR, we have been advocating for our patients for appropriate use of hydroxychloroquine (HCQ) since the drug came to public attention in March. Fortunately, shortages have abated. However, HCQ use in the setting of COVID-19 has brought safety concerns into the public spotlight, particularly regarding possible cardiac toxicity. Providers in clinical practice may be uncertain as to what to tell patients who express anxiety about taking this drug.

Practitioners can highlight that the cardiac risks reported in recent studies are rare in rheumatology patients taking standard doses, although the risk may be higher in COVID-19 patients for reasons including the use of higher dosages of hydroxychloroquine; drug-drug interactions, especially with azathioprine; and the effects of SARS-CoV-2 on the heart. Clinicians should also emphasize that HCQ is the only drug known to reduce death rates in patients with lupus.

Pages: 1 2 3 | Single Page

Filed Under: Legislation & Advocacy, Practice Management, President's Perspective Tagged With: COVID-19, telemedicineIssue: July 2020

You Might Also Like:
  • COVID-19: Practical Tips for Practices
  • COVID-19 Poses Training Challenges for Rheumatology Fellows
  • The ACR on Air Podcast’s COVID-19 Series
  • Financial Impacts of COVID-19 on Practices: Q&A with Norman Gaylis, MD

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.